Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Dominik, Lautsch"'
Autor:
Stephen J. Greene, Hanna K. Gaggin, Mo Zhou, Lori D. Bash, Dominik Lautsch, Laurence Djatche, Yan Song, James Signorovitch, Andra S. Stevenson, Robert O. Blaustein, Javed Butler
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1932-1946 (2024)
Abstract Aims Patients with HFrEF and worsening HF events (WHFE) are at particularly high risk and urgently need disease‐modifying therapy. CHART‐HF assessed treatment patterns and reasons for medication decisions among HFrEF patients with and wi
Externí odkaz:
https://doaj.org/article/fd262287325f47009eb6cbad8faee8cd
Autor:
Giulia Ferrannini, Lina Benson, Dominik Lautsch, Ulf Dahlström, Lars H. Lund, Gianluigi Savarese, Juan Jesus Carrero
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 759-771 (2024)
Abstract Aims In patients with heart failure (HF), we aimed to assess (i) the time trends in N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) testing; (ii) patient characteristics associated with NT‐proBNP testing; (iii) distribution o
Externí odkaz:
https://doaj.org/article/59ce581dec4e433ab5e58689dfa192dd
Autor:
Hanna K. Gaggin, Stephen J. Greene, Mo Zhou, Dominik Lautsch, Lori D. Bash, Laurence Djatche, Yan Song, James Signorovitch, Andra S. Stevenson, Robert O. Blaustein, Javed Butler
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 21, Iss , Pp 200278- (2024)
Background: Based on available data from randomized clinical trials, patients with heart failure with reduced ejection fraction (HFrEF) and worsening HF events (WHFE) have substantial disease burden and poor outcomes. WHFE clinical outcome data in no
Externí odkaz:
https://doaj.org/article/d7dad2a515474427b5c9f5664625db9e
Autor:
Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract This retrospective study was conducted to evaluate all‐cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) and explore end‐of‐life (EOL)‐related HC
Externí odkaz:
https://doaj.org/article/e1731666b6cb444782d67050c24c44a5
Autor:
Tracey J. Weiss, Dena Rosen Ramey, Lingfeng Yang, Xinyue Liu, Mahesh J. Patel, Swapnil Rajpathak, Ednan K. Bajwa, Dominik Lautsch
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Pulmonary hypertension (PH) is a serious complication of chronic obstructive pulmonary disease (COPD). While clinical guidelines recommend specific drug therapies for pulmonary arterial hypertension (PAH), these drug therapies are
Externí odkaz:
https://doaj.org/article/66445654c083426dace805a55e1e63d4
Autor:
Boshu Ru, Xi Tan, Yu Liu, Kartik Kannapur, Dheepan Ramanan, Garin Kessler, Dominik Lautsch, Gregg Fonarow
Publikováno v:
JMIR Formative Research, Vol 7, p e41775 (2023)
BackgroundHeart failure (HF) is highly prevalent in the United States. Approximately one-third to one-half of HF cases are categorized as HF with reduced ejection fraction (HFrEF). Patients with HFrEF are at risk of worsening HF, have a high risk of
Externí odkaz:
https://doaj.org/article/517f98023d794ce28f67f4b879753363
Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare
Autor:
Robert Boggs, PhD, Lingfeng Yang, PhD, Dominik Lautsch, PhD, Dena Rosen Ramey, BA, Sarah Liu, PhD, G. Brandon Atkins, MD, PhD, Ciaran Joseph McMullan, MB, BCh, BAO (Hon), MMSc
Publikováno v:
Kidney Medicine, Vol 5, Iss 2, Pp 100579- (2023)
Externí odkaz:
https://doaj.org/article/e1809db920a84e398c6deba67ee0cbc9
Autor:
James L. Januzzi, Xi Tan, Lingfeng Yang, Joanne E. Brady, Mei Yang, Puja Banka, Dominik Lautsch
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 87-99 (2022)
Abstract Aims The N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a commonly used biomarker in heart failure for diagnosis and prognostication. We aimed to determine the prevalence of NT‐proBNP testing, distribution of NT‐proBNP
Externí odkaz:
https://doaj.org/article/6bbe3ac402084dda9be8a1add32d8d91
Autor:
Wael Al Mahmeed, Sherif Bakir, Salem A Beshyah, Bassem Morcos, Sameh Wajih, Martin Horack, Dominik Lautsch, Baishali Ambegaonkar, Philippe Brudi, Carl A Baxter, Ami Vyas, Anselm K Gitt
Publikováno v:
Heart Views, Vol 20, Iss 2, Pp 37-46 (2019)
Background: Careful management of lipid abnormalities in patients with coronary heart disease (CHD) or an acute coronary syndrome (ACS) can reduce the risk of recurrent cardiovascular events. The extent of hyperlipidemia in these very high-risk patie
Externí odkaz:
https://doaj.org/article/6f70125cea474dc4b4b2bf07d1a93688
Suboptimal adherence to food restrictions requirements related to drug regimens for chronic diseases
Autor:
Robert L. Boggs, Samuel Engel, Tongtong Wang, Tracey Jean Weiss, Ashley A. Martin, Austin Yue, Nate Way, Bryan Ricker, Swapnil N. Rajpathak, Dominik Lautsch
Publikováno v:
Current Medical Research and Opinion. 39:517-522
Oral medications for chronic conditions often involve a variety of instructions, including time of day/dosing, drug interactions, and food intake restrictions. However, the extent to which patients follow these instructions is unclear. We surveyed pa